Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
JAMA Health Forum|February 9, 2024
Acute Diabetes Complications After Transition to a Value-Based Medication BenefitJ Franklin Wharam, Stephanie Argetsinger, Matthew Lakoma, et al.The American Journal of Managed Care|August 19, 2025
Trends in insulin out-of-pocket costs and use disparities, 2008-2021Elise S Tremblay, Stephanie Argetsinger, Fang Zhang, et al.Journal of Addiction Medicine|February 11, 2026
Opioid Use Disorder Care Presentations After High-deductible Health Plan EnrollmentBryant Shuey, Fang Zhang, Stephanie Argetsinger, et al.Annals of Internal Medicine|March 25, 2024
Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use Among Commercially Insured Patients With Diabetes : A Pre-Post Study With a Control GroupLaura F Garabedian, Fang Zhang, Rebecca Costa, et al.Diabetes Care|October 8, 2024
Effects of Adopting Preventive Drug Lists on Medication Costs and Disparities by Income Over 2 Years: A Natural Experiment for Translation in Diabetes (NEXT-D) StudyChristine Y Lu, Stephanie Argetsinger, Matthew Lakoma, et al.The American Journal of Managed Care|August 19, 2025
More employers offer preventive drug lists over timeAnita K Wagner, Stephanie Argetsinger, Matt Lakoma, et al.Medical Care|July 29, 2025
Preventive Drug Lists Reduce Income-Related Disparities in Medication Adherence Over 2 Years: A Natural Experiment for Translation in Diabetes (NEXT-D) StudyDennis Ross-Degnan, Stephanie Argetsinger, Christine Y Lu, et al.The Journal of Pediatrics|December 14, 2025
Assessment of Oral Anti-Cancer Medicines in Pediatric Patients Before the RACE Act, 2007-2021Mahnum Shahzad, Steven G DuBois, Rebecca Costa, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2024
Financial Toxicity of Withdrawn Poly (Adenosine Diphosphate Ribose) Polymerase Inhibitor Indications for Ovarian CancerJoseph A Dottino, Katharine M Esselen, Rebecca Costa, et al.Health Services Research|November 5, 2024
The impact of a payer-provider joint venture on healthcare valueLaura F Garabedian, J Frank Wharam, Joseph P Newhouse, et al.Pageof 3